Microbiology
M001: Emerging New "Pseudomonas" Species in Cystic Fibrosis. - P. Vandamme,
M002: Molecular Epidemiology of Pseudomonas Aeruginosa Infection in Cystic Fibrosis Patients - M.J. Struelens,
M003: Molecular Epidemiology of Burkholderia (Pseudomonas) Cepacia . - H.Revets and S.Lauwers.
M004: Resistance to Antimicrobial Therapy in Pseudomonas Aeruginosa Infection - N. Høiby
M005: Meropenem is Efficient for Treatment of Chronic Lung Infection with Resistant P. Aeruginosa and B.Cepacia in Cystic Fibrosis (CF) Patients. - O.Ciofu, T.Jensen, T.Pressler, et al
M006: Burkholderia (Pseudomonas) Cepacia Pulmonary Colonization in Patients with Cystic Fibrosis (CF): A Two Years Epidemiological Follow-up in France - C.Segonds, E.Bingen, G.Couetdic, et al
M007: A Safety Profile of Intravenous Colomycin in Adult CF Care. - S.P. Conway., M. Pond, A. Watson, et al
M008: Bacterial Lung Infection and Clinical Status in Cystic Fibrosis. - H C Ryley, M. Desai, P Sebire, et al
M009: Survival and Multiplication of Burkholderia (Pseudomonas) Cepacia within the Free-Living Amoeba Acanthamoeba Polyphaga. - P.D. Landers, J.L Tipper, T.J. Rowbotham & K.G. Kerr
M010: Is Strict Isolation of Pseudomonas Cepacia [PC] Positive Patients Necessary? - S.P. Conway, M.N. Pond, D.S. Tompkins.
M011: Pseudomonas Aeruginosa and Burkholderia Cepacia Infection in Danish and Canadian Cystic Fibrosis Patients. - T. Kovesi, M. Corey, H. Levison & N. Høiby
M012: Polymerase Chain Reaction for Detection of Pseudomonads in Sputum of Patients with Cystic Fibrosis - F. Karpati, J. Jonasson and A-S. Malmborg
M013: Chronic Colonization by Alcaligenes Xylosoxidans in Cystic Fibrosis Children: Clinical Retrospective Study and Investigation by DNA Restriction Fragment Length Polymorphism - A. Baculard , D. Moissenet, H. Vu Thien, et al
M014: Burkholderia Cepacia: Clinical Impact on Cystic Fibrosis (CF) Patients in Genoa Center - L. Minicucci, B. Tubino, M.C. Diana, et al
M015: A Study of Strain Variation in Burkholderia (Pseudomonas) Cepacia in Patients with Cystic Fibrosis using Multi-Locus Enzyme Electrophoresis - J.T. McCaughan, A. Coffey, K.B. Bamford, et al
M016: Low Bacterial Contamination of Nebulizers - B-M Jakobsson, A-B. Önnered, B. Nyström, et al
M017: Stenotrophomonas maltophilia in Cystic Fibrosis Patients - S. Ballestero, ME Alvarez, H. Escobar et al
M018: Colonization by Burkholderia Cepacia and Cystic Fibrosis: Study of Epidemiologic Markers of Strains Isolated of Three Health Care Centers in Brittany. - F.Autul,Y, P.Y.Donnio, J. Tubert, et al
M019: A Novel Selective Culture Medium Reveals a Previously Underestimated Prevalence of Stenotrophomonas (Xanthomonas) Maltophilia in a Cystic Fibrosis Clinic - M Denton., MJ Hall, NJ Todd, JM Littlewood
M020: Colonisation and Transmission with Burkholderia Cepacia in a French Cystic Fibrosis (CF) Centre - Carrère J., Mathieu L., Segonds C. et al
M021: Differentiation of Burkholderia (Pseudomonas) Gladioli and Clinical and Environmental Strains of Burkholderia Cepacia by Multiple Arbitrary Amplicon Profiling (MAAP). - J.L. Tipper., E. Ingham, J.H. Cove, et al
M022: An Immunofluorescent Assay for Determining the Invasiveness of A549 Cells by Burkholderia (Pseudomonas) Cepacia. - J.L. Tipper, E. Ingham, J.H. Cove, et al
M023: Typing by Antibiogram, Pyocin Suscetibilty, and AP-PCR of P. Aeruginosa from Cystic Fibrosis Patients. - Campana S.. Rovai C., et al
M024: Xanthomonas Maltophilia Chronic Lung Infection in CF Patients: Epidemiology, Antibiotics Sensitivity, Influence on Clinical Course. - Piamaroli A.,Marzano M.T.,Levi R., et al
M025: Molecular Microbial Ecology Studies on Pseudomonas Aeruginosa Isolates from Cystic Fibrosis Patients: The Role of Iron in the Regulation of Virulence Related Factors - C. Adams, Declan Hickey, Mary Morris-Quinn et al
M026: Quinoline Therapy in Children with Cystic Fibrosis - N Kapranov, YB Belousov, NY Kashyrskaya, EY Smirnova.
M027: Changes in Sputum Mycobacteriology of Patients with Cystic Fibrosis who use Pulmozyme Regularly - K.Mavunda, R.M.McKey, M.Barrueco, et al
M028: Kidney Tolerance of High Dose Regimen of Aminoglycoside Antibiotic Treatment in CF - L.Marzullo, M.Pelegrini, B.Tubino, et al
M029: The Possible Role of Dormancy in Cystic Fibrosis Lung Infections with Pseudomonas Aeruginosa and Burkholderia Cepacia - M. Desai, B. Baretto, S. Ballestero, et al
M030: Alcaligenes Xylosoxidans Subspp. Xylosoxidans Chronic Colonisation in Cystic Fibrosis Patients: Presence of Serum Antibodies Detected by ELISA Assay - E.Ugolotti, G. Manno, M.L. Belli et al
M031: Bacteriological Study of Sputum in CF Patients Receiving once-Daily Amikacin for Pseudomonas Aeruginosa Pulmonary Exacerbations. - F. Canis, MO Husson, Ph Vic, S Ategbo, et al
M032: Increased Isolation of Uncommon Multiresistant Non-Fermenting Organisms in Cystic Fibrosis - M.L.Belli . G.Manno, E.Ugolotti, et al
M033: Exophiala dermatitidis in patients with cystic fibrosis: a survey in the Netherlands - Mouton JW, Brimicombe R, Weel J, et al
M034: Pharmacokinetics of Ciplrofloxacin in Children with Cystic Fibrosis - C. Montes, A. Munck, M. Gerardin, et al
M035: Pseudomonas Cepacia Infections in Cystic Fibrosis Children: Epidemiological Investigatlon by Analysis of DNA Restriction Fragment Length Polymorphism - D Moissenet, M. Valcin, A. Baculard et al
M036: Study of bacterial and fungal flora in respiratory tract specimens from Cystic Fibrosis (CF) patients - M.E. Alvarez, J.J. Velasco-Martínez, R.Cantón et al
M037: Quantitative Methods to Evaluate Pseudomonas Aeruginosa Adherence to Respiratory Epithelium. - S.Girod de Bentzmann,. Roger P, Bonnet N., Puchelle E.
M038: Quinolone Resistance in Haemophilus influenzae Isolates from Cystic Fibrosis Patients. - R. Cantón, M.E. Alvarez, M. Alvarez et al
M039: Clonal Analysis of Pseudomonas Aeruginosa from Chronically Colonized Patients with Cystic Fibrosis: The value of phenotypic versus genotypic procedures. - Nicole Renders, Alex van Belkum, Afonso Barth, et al
M040: O-antigen localization with immunoelectron microscopy in P. aeruginosa isolates from patients with cystic fibrosis using polyclonal versus monoclonal antibodies. - A.M. Horrevorts G. Pool, H. van Lee, et al
M041: Itraconazole Treatment of Allergic Broncho Pulmonary Aspergillosis in Cystic Fibrosis Children - C. Marguet, N. Sannier, O. Mouterde, E. Mallet
M042: The Role of Infections in the Pathogenesis of Arthritis in Cystic Fibrosis Patients - Dr M Al-Shamma, Dr E McCruden & Dr B Stack
M043: The Induction of TNF by B. Cepacia and P. Aeruginosa Lipopolysaccharide.- D. Shaw, I.R. Poxton and J.R.W. Govan
M044: Viral Respiratory Tract Infections in Patients with Cystic Fibrosis - J. Collinson, J. Ashman, E. Cancio et al
M045: Haemophilus Influenzae in Patients with Cystic Fibrosis : B. Przykenk & A. Bauernfeind
M046: Evidence for AsialoGM1 as a Glycolipid Receptor for Pseudomonas Aeruginosa Adherence to Repairing Respiratory Epithelium. - S. Girod de Bentzmann,. Roger P., Bajolet-Laudinat O. and Puchelle E